Frantz Viral Therapeutics, LLC

Quick facts

Phase 3 pipeline

• Placebo vaginal insert
  A placebo vaginal insert contains no active pharmaceutical ingredient and serves as a control comparator in clinical trials.

Phase 2 pipeline

• Artesunate vaginal insert · Infectious Disease
  Artesunate is a derivative of artemisinin that targets the heme moiety of the malaria parasite, disrupting its 80-kDa protein.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Frantz Viral Therapeutics, LLC portfolio CI brief
• Frantz Viral Therapeutics, LLC pipeline updates RSS